Antibacterial activity of retinaldehyde against propionibacterium acnes

Dermatology

Volumn 199, Issue SUPPL. 1, 1999, Pages 29-31

  Pechère, Marc ^a   Pechere J C ^b   Siegenthaler, G ^a   Germanier, L ^a   Saurat, J H ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Propionibacterium acnes; Topical retinaldehyde

Indexed keywords

RETINAL;

ANTIBACTERIAL ACTIVITY; BACTERIAL COUNT; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; RETINALDEHYDE; SINGLE-BLIND METHOD; SKIN; TRETINOIN;

EID: 17744414216     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051375     Document Type: Conference Paper

References (17)

1. Green HN, Mellanby E: Vitamin A as an anti-infective agent. Br Med J 1928;ii:691-696.
2. Cohen BE, Elin RJ: Vitamin A induced nonspecific resistance to infection. J Infect Dis 1974; 129:597-600.
3. Krishnan S, Krishnan AD, Mustapha AS, Talwar GP, Ramalingaswami V: Effect of vitamin A and undernutrition on the susceptibility of rodents to a malarial parasite, plasmodium berghei. J Nutr 1976;106:784-791.
4. Bang FB, Bang BG, Foard M: Acute Newcastle disease virus infection of the upper respiratory tract of the chicken. The effect of diets deficient in vitamin A on the pathogenesis of the infection. Am J Pathol 1975;79:417-424.
5. Nauss KM, Anderson CA, Connors MW, Newberne PM: Ocular infection with herpes simplex virus (HSV-1) infection. J Nutr 1985;115: 1300-1315.
6. Ross AC, Hämmerling UG: Retinoids and the immune system; in Sporn MB, Roberts AB, Goodman DS (eds): The retinoids: Biology, Chemistry and Medecine, ed 2. New York, Raven Press, 1994, pp 597-630.
7. Pechère M, Siegenthaler G, Pechère JL, Saurat J-H: Antibacterial effect of retinaldehyde and derivatives (abstract). J Invest Dermatol 1996; 106:912.
8. Leyden JJ, McGinley KJ, Nordstrom KM, Webster GF: Skin microflora. J Invest Dermatol 1987;88:S65-S71.
9. National Comittee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, ed 2. approved standard. Villanova, NCCLS, 1990, vol 8.
10. Williamson P, Kligman AM: A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 1965;45:498-530.
11. Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, Butkus D, Arnaud-Batendier J: Prolonged remission of cystic and conglomata acne with 13-cis-retinoic acid. N Engl J Med 1979;300:329-333.
12. Plewig G, Nikolowski J, Wolff HH: Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol 1983;6:766-785.
13. Leyden JJ, McGinley KJ, Foglia AN: Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 1986;86:390-393.
14. Weissmann A, Wagner A, Plewig G: Reduction of bacterial skin flora during oral treatment of severe acne with 13-cis-retinoic acid. Arch Dermatol Res 1981;270:179-183.
15. Simjee S, Sahm DF, Soltani K, Morello JA: Organisms associated with gram-negative folliculitis: In vitro growth in the presence of isotretinoin. Arch Dermatol Res 1986;278:314-316.
16. Flemetakis AC, Tsambaos DG: Effects of synthetic retinoids on the growth of bacteria and their susceptibility to antibiotics. J Chemother 1989;1:374-376.
17. McGinley KJ, Webster GF, Leyden JJ: Regional variations of cutaneous propionibacteria. Appl Environ Microbiol 1974;35:62-65.